Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Grace Therapeutics Inc GRCE

Healthcare Biotechnology
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company’s lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a... see more

Recent & Breaking News (NDAQ:GRCE)

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022

GlobeNewswire February 14, 2022

Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call

GlobeNewswire February 7, 2022

Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference

GlobeNewswire January 3, 2022

Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104

GlobeNewswire December 2, 2021

Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd

GlobeNewswire November 24, 2021

Acasti Pharma Announces Annual Stock Option Grants

GlobeNewswire November 12, 2021

Acasti Pharma To Present At The Q4 Investor Summit on November 16th

Newsfile November 11, 2021

Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022

GlobeNewswire November 10, 2021

Acasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference Call

GlobeNewswire November 4, 2021

Acasti Pharma (TSXV:ACST) awarded composition-of-matter patents

Brieanna McCutcheon  October 6, 2021

Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan

GlobeNewswire October 6, 2021

Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Company's Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage

GlobeNewswire September 27, 2021

Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards

GlobeNewswire September 22, 2021

Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ

GlobeNewswire September 14, 2021

Acasti Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

GlobeNewswire September 8, 2021

Acasti Pharma (TSXV:ACST) announces successful merger with Grace Therapeutics

Julia Kennedy  August 27, 2021

Acasti Pharma Announces Successful Completion of its Merger with Grace Therapeutics, Inc., Voting Results of its Annual and Special Meeting of Shareholders and Reverse Stock Split

GlobeNewswire August 27, 2021

Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022

GlobeNewswire August 12, 2021

Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics

GlobeNewswire July 29, 2021

Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics

GlobeNewswire July 23, 2021

Podcasts